Clinical Trial Update: MMV390048 Against Early Plasmodium Falciparum Blood Stage Infection in Healthy Participants [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating MMV390048 for early blood-stage infection of Falciparum malaria in healthy participants; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Falciparum Malaria
• Malaria

Drugs mentioned

• MMV390048 (MMV390048)

Snippet

Sponsor: Medicines for Malaria Venture | Conditions: Malaria, Falciparum | Phase 1 | Status: TERMINATED | Results posted: 2020-06-09